Translational Insights in Regenerative Medicine

Erscheinungsjahr 2027
ISBN: 978-0-443-43258-3
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 152 mm x 229 mm

Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

Autoren/Hrsg.

Weitere Mitwirkende

Kumar, Dhruv

Fachgebiete

• Naturwissenschaften Physik Angewandte Physik Biophysik
• Naturwissenschaften Biowissenschaften Molekularbiologie
• Naturwissenschaften Biowissenschaften Biowissenschaften Genetik und Genomik (nichtmedizinisch)
• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)

Inhaltsverzeichnis

1. Introduction to Molecular and Systems Biology in Health and Disease
DHRUV KUMAR
2. Multi-Omics Approaches in Disease Pathophysiology
3. Bioinformatics and Computational Modeling in Regenerative Medicine
4. Stem Cell Biology and Tissue Regeneration
Simran Tandon
5. Biomaterials and 3D Bioprinting for Organ Engineering
Giampaolo Zuccheri
6. CRISPR and Gene Editing in Regenerative Medicine
7. Systems Immunology and Immune Modulation in Disease Therapy
Rajesh Kumar Yadav
8. Cancer Immunotherapy: Advances and Challenges
9. Autoimmune Diseases and Novel Immunomodulatory Therapies
10. Regenerative Medicine in Neurodegenerative Diseases
11. Metabolic Disorders and Targeted Therapies
12. Cardiovascular and Musculoskeletal Regeneration
Anil A. Chuturgoon
13. Artificial Intelligence and Robotics in Healthcare
Arjun Ray
14. Regulatory and Ethical Challenges in Regenerative Medicine and Immunology
Ashok Kumar
15. Future Directions in Systems Biology for Disease Prevention and Treatment
DHRUV KUMAR

Über Autor(innen)

Kumar, Dhruv
Dr. Dhruv Kumar is a Senior Associate Professor at School of Health Sciences and Technology, UPES University, Dehradun, India and his current research is focused on autophagy, cancer cell metabolism, tumour microenvironment, exosomes, mutational heterogeneity, cancer prevention, drug designing, NGS and COVID-19. After completion of B.Sc. in Chemistry from Banaras Hindu University (BHU) and M.Sc. in Bioinformatics from University of Allahabad, India, he has completed his Ph.D. in Cellular, Molecular and Industrial Biology from the University of Bologna (UNIBO), under highly prestigious fellowship, Indo-Italian Government fellowship. After his Ph.D., he obtained Postdoctoral training at the University of Kansas Medical Center, USA. During his Postdoctoral training, he worked towards understanding the molecular mechanism(s) of autophagy regulation and apoptosis in cancer stem cells (prostate, pancreatic and breast), focusing on the metabolic cross-talk between the tumour microenvironment (cancer associated fibroblast (CAF)) and head and neck squamous cell carcinoma (HNSCC) via HGF/c-MET and bFGF/FGFR signalling pathways. He has also worked on structure based drug designing for several cancers, COVID-19, mutational heterogeneity in cancer. Currently, his lab is focusing on metabolic heterogeneity in solid tumours and structure based drug designing for cancer and COVID-19. He has published more than 100 research articles, reviews and book chapters in reputed journals.